Project
Illumina Body Map 2
Navigation
Downloads
Results for RAD21_SMC3
Z-value: 1.24
Motif logo
Transcription factors associated with RAD21_SMC3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
RAD21
|
ENSG00000164754.8 | RAD21 cohesin complex component |
|
SMC3
|
ENSG00000108055.9 | structural maintenance of chromosomes 3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| RAD21 | hg19_v2_chr8_-_117886563_117886605 | -0.17 | 3.5e-01 | Click! |
| SMC3 | hg19_v2_chr10_+_112327425_112327516 | 0.09 | 6.2e-01 | Click! |
Activity profile of RAD21_SMC3 motif
Sorted Z-values of RAD21_SMC3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr22_+_22697537 | 3.55 |
ENST00000427632.2
|
IGLV9-49
|
immunoglobulin lambda variable 9-49 |
| chr22_+_22735135 | 3.53 |
ENST00000390297.2
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
| chr22_+_22786288 | 3.38 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
| chr8_-_27850180 | 3.31 |
ENST00000380385.2
ENST00000301906.4 ENST00000354914.3 |
SCARA5
|
scavenger receptor class A, member 5 (putative) |
| chr22_+_22764088 | 3.24 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
| chr22_+_23040274 | 3.04 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
| chr22_+_22723969 | 2.97 |
ENST00000390295.2
|
IGLV7-46
|
immunoglobulin lambda variable 7-46 (gene/pseudogene) |
| chr2_+_114737472 | 2.95 |
ENST00000420161.1
|
AC110769.3
|
AC110769.3 |
| chr14_+_94405901 | 2.88 |
ENST00000557646.1
|
RP11-131H24.4
|
Uncharacterized protein |
| chr8_-_27850141 | 2.72 |
ENST00000524352.1
|
SCARA5
|
scavenger receptor class A, member 5 (putative) |
| chr17_+_1958388 | 2.51 |
ENST00000399849.3
|
HIC1
|
hypermethylated in cancer 1 |
| chr14_-_75079026 | 2.48 |
ENST00000261978.4
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
| chr7_-_27219849 | 2.46 |
ENST00000396344.4
|
HOXA10
|
homeobox A10 |
| chr11_+_1897697 | 2.40 |
ENST00000432093.1
|
LSP1
|
lymphocyte-specific protein 1 |
| chr19_+_48216600 | 2.36 |
ENST00000263277.3
ENST00000538399.1 |
EHD2
|
EH-domain containing 2 |
| chr22_+_22550113 | 2.36 |
ENST00000390285.3
|
IGLV6-57
|
immunoglobulin lambda variable 6-57 |
| chr10_-_76868931 | 2.34 |
ENST00000372700.3
ENST00000473072.2 ENST00000491677.2 ENST00000607131.1 ENST00000372702.3 |
DUSP13
|
dual specificity phosphatase 13 |
| chr7_+_142334156 | 2.33 |
ENST00000390394.3
|
TRBV20-1
|
T cell receptor beta variable 20-1 |
| chr17_-_48277552 | 2.26 |
ENST00000507689.1
|
COL1A1
|
collagen, type I, alpha 1 |
| chr10_+_17272608 | 2.25 |
ENST00000421459.2
|
VIM
|
vimentin |
| chr14_+_22337014 | 2.22 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
| chr14_-_75079294 | 2.21 |
ENST00000556359.1
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
| chr22_+_22749343 | 2.20 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
| chr16_+_55357672 | 2.17 |
ENST00000290552.7
|
IRX6
|
iroquois homeobox 6 |
| chr14_+_22386325 | 2.10 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
| chr7_-_38394118 | 2.06 |
ENST00000390345.2
|
TRGV4
|
T cell receptor gamma variable 4 |
| chr19_-_55652290 | 2.05 |
ENST00000589745.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr16_-_15950868 | 2.04 |
ENST00000396324.3
ENST00000452625.2 ENST00000576790.2 ENST00000300036.5 |
MYH11
|
myosin, heavy chain 11, smooth muscle |
| chr14_+_22356029 | 2.02 |
ENST00000390437.2
|
TRAV12-2
|
T cell receptor alpha variable 12-2 |
| chr14_+_22362613 | 2.01 |
ENST00000390438.2
|
TRAV8-4
|
T cell receptor alpha variable 8-4 |
| chr14_+_22446680 | 1.99 |
ENST00000390443.3
|
TRAV8-6
|
T cell receptor alpha variable 8-6 |
| chr14_+_52118576 | 1.98 |
ENST00000395718.2
ENST00000344768.5 |
FRMD6
|
FERM domain containing 6 |
| chr14_+_22309368 | 1.98 |
ENST00000390433.1
|
TRAV12-1
|
T cell receptor alpha variable 12-1 |
| chr15_-_64338521 | 1.95 |
ENST00000457488.1
ENST00000558069.1 |
DAPK2
|
death-associated protein kinase 2 |
| chr10_-_30024716 | 1.93 |
ENST00000375398.2
ENST00000375400.3 |
SVIL
|
supervillin |
| chr6_-_41703296 | 1.85 |
ENST00000373033.1
|
TFEB
|
transcription factor EB |
| chr14_+_22265444 | 1.83 |
ENST00000390430.2
|
TRAV8-1
|
T cell receptor alpha variable 8-1 |
| chr16_-_49891694 | 1.83 |
ENST00000562520.1
|
ZNF423
|
zinc finger protein 423 |
| chr14_+_22465771 | 1.81 |
ENST00000390445.2
|
TRAV17
|
T cell receptor alpha variable 17 |
| chr19_-_55653259 | 1.78 |
ENST00000593194.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr1_+_28844778 | 1.72 |
ENST00000411533.1
|
RCC1
|
regulator of chromosome condensation 1 |
| chr14_+_22217447 | 1.72 |
ENST00000390427.3
|
TRAV5
|
T cell receptor alpha variable 5 |
| chr10_+_104154229 | 1.70 |
ENST00000428099.1
ENST00000369966.3 |
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
| chr1_+_28844648 | 1.68 |
ENST00000373832.1
ENST00000373831.3 |
RCC1
|
regulator of chromosome condensation 1 |
| chr9_-_22009241 | 1.65 |
ENST00000380142.4
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
| chr21_-_44846999 | 1.63 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
| chr6_+_138188351 | 1.62 |
ENST00000421450.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
| chr11_-_65359947 | 1.61 |
ENST00000597463.1
|
AP001362.1
|
Uncharacterized protein |
| chr19_+_49977466 | 1.60 |
ENST00000596435.1
ENST00000344019.3 ENST00000597551.1 ENST00000204637.2 ENST00000600429.1 |
FLT3LG
|
fms-related tyrosine kinase 3 ligand |
| chr7_-_27219632 | 1.60 |
ENST00000470747.4
|
RP1-170O19.20
|
Uncharacterized protein |
| chr14_+_81421710 | 1.53 |
ENST00000342443.6
|
TSHR
|
thyroid stimulating hormone receptor |
| chr10_-_15762124 | 1.47 |
ENST00000378076.3
|
ITGA8
|
integrin, alpha 8 |
| chr12_-_7245152 | 1.46 |
ENST00000542220.2
|
C1R
|
complement component 1, r subcomponent |
| chr12_-_7245018 | 1.44 |
ENST00000543835.1
ENST00000535233.2 |
C1R
|
complement component 1, r subcomponent |
| chr10_+_99332198 | 1.43 |
ENST00000307518.5
ENST00000298808.5 ENST00000370655.1 |
ANKRD2
|
ankyrin repeat domain 2 (stretch responsive muscle) |
| chr5_+_54455946 | 1.43 |
ENST00000503787.1
ENST00000296734.6 ENST00000515370.1 |
GPX8
|
glutathione peroxidase 8 (putative) |
| chr22_+_23063100 | 1.41 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
| chr3_-_128212016 | 1.41 |
ENST00000498200.1
ENST00000341105.2 |
GATA2
|
GATA binding protein 2 |
| chr19_-_49496557 | 1.40 |
ENST00000323798.3
ENST00000541188.1 ENST00000544287.1 ENST00000540532.1 ENST00000263276.6 |
GYS1
|
glycogen synthase 1 (muscle) |
| chr12_-_7245125 | 1.39 |
ENST00000542285.1
ENST00000540610.1 |
C1R
|
complement component 1, r subcomponent |
| chr19_-_4400415 | 1.38 |
ENST00000598564.1
ENST00000417295.2 ENST00000269886.3 |
SH3GL1
|
SH3-domain GRB2-like 1 |
| chr14_+_81421355 | 1.36 |
ENST00000541158.2
|
TSHR
|
thyroid stimulating hormone receptor |
| chr15_-_79103757 | 1.36 |
ENST00000388820.4
|
ADAMTS7
|
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
| chr7_-_100171270 | 1.36 |
ENST00000538735.1
|
SAP25
|
Sin3A-associated protein, 25kDa |
| chr12_-_7245080 | 1.35 |
ENST00000541042.1
ENST00000540242.1 |
C1R
|
complement component 1, r subcomponent |
| chr1_-_186344802 | 1.35 |
ENST00000451586.1
|
TPR
|
translocated promoter region, nuclear basket protein |
| chr14_+_23305760 | 1.34 |
ENST00000311852.6
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted) |
| chr3_-_142607740 | 1.33 |
ENST00000485766.1
|
PCOLCE2
|
procollagen C-endopeptidase enhancer 2 |
| chr2_+_90108504 | 1.32 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
| chr5_-_44388899 | 1.32 |
ENST00000264664.4
|
FGF10
|
fibroblast growth factor 10 |
| chr10_-_6019984 | 1.31 |
ENST00000525219.2
|
IL15RA
|
interleukin 15 receptor, alpha |
| chr17_+_45810594 | 1.30 |
ENST00000177694.1
|
TBX21
|
T-box 21 |
| chr5_+_148521454 | 1.30 |
ENST00000508983.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr18_+_43753500 | 1.30 |
ENST00000587591.1
ENST00000588730.1 |
C18orf25
|
chromosome 18 open reading frame 25 |
| chr14_+_22508822 | 1.29 |
ENST00000390448.3
|
TRAV20
|
T cell receptor alpha variable 20 |
| chr17_-_8868991 | 1.27 |
ENST00000447110.1
|
PIK3R5
|
phosphoinositide-3-kinase, regulatory subunit 5 |
| chr4_-_164253738 | 1.27 |
ENST00000509586.1
ENST00000504391.1 ENST00000512819.1 |
NPY1R
|
neuropeptide Y receptor Y1 |
| chr19_-_6481759 | 1.26 |
ENST00000588421.1
|
DENND1C
|
DENN/MADD domain containing 1C |
| chr22_+_22936998 | 1.26 |
ENST00000390303.2
|
IGLV3-32
|
immunoglobulin lambda variable 3-32 (non-functional) |
| chr22_+_19744226 | 1.26 |
ENST00000332710.4
ENST00000329705.7 ENST00000359500.3 |
TBX1
|
T-box 1 |
| chr9_-_134615443 | 1.26 |
ENST00000372195.1
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1 |
| chr10_-_76868866 | 1.24 |
ENST00000607487.1
|
DUSP13
|
dual specificity phosphatase 13 |
| chr14_+_22236722 | 1.23 |
ENST00000390428.3
|
TRAV6
|
T cell receptor alpha variable 6 |
| chr2_-_232571621 | 1.23 |
ENST00000595658.1
|
MGC4771
|
MGC4771 |
| chr9_-_94712434 | 1.21 |
ENST00000375708.3
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2 |
| chr14_+_52118694 | 1.21 |
ENST00000554778.1
|
FRMD6
|
FERM domain containing 6 |
| chr17_+_72199721 | 1.21 |
ENST00000439590.2
ENST00000311111.6 ENST00000584577.1 ENST00000534490.1 ENST00000528433.2 ENST00000533498.1 |
RPL38
|
ribosomal protein L38 |
| chr7_+_89783689 | 1.20 |
ENST00000297205.2
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1 |
| chr10_+_99332529 | 1.19 |
ENST00000455090.1
|
ANKRD2
|
ankyrin repeat domain 2 (stretch responsive muscle) |
| chr14_+_22788560 | 1.18 |
ENST00000390468.1
|
TRAV41
|
T cell receptor alpha variable 41 |
| chr4_+_75858318 | 1.17 |
ENST00000307428.7
|
PARM1
|
prostate androgen-regulated mucin-like protein 1 |
| chr14_+_23305783 | 1.17 |
ENST00000547279.1
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted) |
| chr1_+_93297622 | 1.17 |
ENST00000315741.5
|
RPL5
|
ribosomal protein L5 |
| chr17_+_42427826 | 1.17 |
ENST00000586443.1
|
GRN
|
granulin |
| chr6_+_138188378 | 1.16 |
ENST00000420009.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
| chr6_+_138188551 | 1.16 |
ENST00000237289.4
ENST00000433680.1 |
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
| chr12_-_120638902 | 1.16 |
ENST00000551150.1
ENST00000313104.5 ENST00000547191.1 ENST00000546989.1 ENST00000392514.4 ENST00000228306.4 ENST00000550856.1 |
RPLP0
|
ribosomal protein, large, P0 |
| chr12_-_120703523 | 1.15 |
ENST00000267257.7
ENST00000228307.7 ENST00000424649.2 |
PXN
|
paxillin |
| chr16_-_69788816 | 1.15 |
ENST00000268802.5
|
NOB1
|
NIN1/RPN12 binding protein 1 homolog (S. cerevisiae) |
| chr2_-_75426826 | 1.13 |
ENST00000305249.5
|
TACR1
|
tachykinin receptor 1 |
| chr5_+_137688285 | 1.13 |
ENST00000314358.5
|
KDM3B
|
lysine (K)-specific demethylase 3B |
| chr9_+_116917807 | 1.12 |
ENST00000356083.3
|
COL27A1
|
collagen, type XXVII, alpha 1 |
| chr8_-_48651648 | 1.12 |
ENST00000408965.3
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta |
| chr5_-_146833485 | 1.12 |
ENST00000398514.3
|
DPYSL3
|
dihydropyrimidinase-like 3 |
| chr19_+_4791722 | 1.11 |
ENST00000269856.3
|
FEM1A
|
fem-1 homolog a (C. elegans) |
| chr15_+_63340775 | 1.11 |
ENST00000559281.1
ENST00000317516.7 |
TPM1
|
tropomyosin 1 (alpha) |
| chr16_-_11350036 | 1.11 |
ENST00000332029.2
|
SOCS1
|
suppressor of cytokine signaling 1 |
| chr10_-_76995769 | 1.10 |
ENST00000372538.3
|
COMTD1
|
catechol-O-methyltransferase domain containing 1 |
| chr4_+_75858290 | 1.09 |
ENST00000513238.1
|
PARM1
|
prostate androgen-regulated mucin-like protein 1 |
| chr11_-_117103208 | 1.09 |
ENST00000320934.3
ENST00000530269.1 |
PCSK7
|
proprotein convertase subtilisin/kexin type 7 |
| chr10_+_102759045 | 1.09 |
ENST00000370220.1
|
LZTS2
|
leucine zipper, putative tumor suppressor 2 |
| chr9_-_134615326 | 1.08 |
ENST00000438647.1
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1 |
| chr19_+_5690297 | 1.08 |
ENST00000582463.1
ENST00000579446.1 ENST00000394580.2 |
RPL36
|
ribosomal protein L36 |
| chr19_+_5690207 | 1.07 |
ENST00000347512.3
|
RPL36
|
ribosomal protein L36 |
| chr2_+_69240511 | 1.07 |
ENST00000409349.3
|
ANTXR1
|
anthrax toxin receptor 1 |
| chr19_-_35626104 | 1.06 |
ENST00000310123.3
ENST00000392225.3 |
LGI4
|
leucine-rich repeat LGI family, member 4 |
| chr4_-_41884620 | 1.06 |
ENST00000504870.1
|
LINC00682
|
long intergenic non-protein coding RNA 682 |
| chr10_-_76995675 | 1.05 |
ENST00000469299.1
|
COMTD1
|
catechol-O-methyltransferase domain containing 1 |
| chr1_+_185703513 | 1.03 |
ENST00000271588.4
ENST00000367492.2 |
HMCN1
|
hemicentin 1 |
| chr19_-_41859814 | 1.03 |
ENST00000221930.5
|
TGFB1
|
transforming growth factor, beta 1 |
| chr2_+_234263120 | 1.02 |
ENST00000264057.2
ENST00000427930.1 |
DGKD
|
diacylglycerol kinase, delta 130kDa |
| chr6_-_41673552 | 1.02 |
ENST00000419574.1
ENST00000445214.1 |
TFEB
|
transcription factor EB |
| chr16_-_89008211 | 1.01 |
ENST00000569464.1
ENST00000569443.1 |
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
| chr1_+_37940153 | 1.01 |
ENST00000373087.6
|
ZC3H12A
|
zinc finger CCCH-type containing 12A |
| chr20_+_30102231 | 1.00 |
ENST00000335574.5
ENST00000340852.5 ENST00000398174.3 ENST00000376127.3 ENST00000344042.5 |
HM13
|
histocompatibility (minor) 13 |
| chr17_-_40833858 | 1.00 |
ENST00000332438.4
|
CCR10
|
chemokine (C-C motif) receptor 10 |
| chr2_-_89459813 | 1.00 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
| chr19_-_19754404 | 1.00 |
ENST00000587205.1
ENST00000445806.2 ENST00000203556.4 |
GMIP
|
GEM interacting protein |
| chr2_+_69240302 | 0.99 |
ENST00000303714.4
|
ANTXR1
|
anthrax toxin receptor 1 |
| chr19_-_19051927 | 0.99 |
ENST00000600077.1
|
HOMER3
|
homer homolog 3 (Drosophila) |
| chr22_-_22292934 | 0.99 |
ENST00000538191.1
ENST00000424647.1 ENST00000407142.1 |
PPM1F
|
protein phosphatase, Mg2+/Mn2+ dependent, 1F |
| chr19_-_19754354 | 0.98 |
ENST00000587238.1
|
GMIP
|
GEM interacting protein |
| chr3_+_50192457 | 0.97 |
ENST00000414301.1
ENST00000450338.1 |
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr2_+_131113609 | 0.96 |
ENST00000347849.3
|
PTPN18
|
protein tyrosine phosphatase, non-receptor type 18 (brain-derived) |
| chr6_+_160769399 | 0.96 |
ENST00000392145.1
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3 |
| chr15_+_75074410 | 0.95 |
ENST00000439220.2
|
CSK
|
c-src tyrosine kinase |
| chr5_+_148521381 | 0.95 |
ENST00000504238.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr8_-_145550337 | 0.95 |
ENST00000531896.1
|
DGAT1
|
diacylglycerol O-acyltransferase 1 |
| chr8_+_17434689 | 0.94 |
ENST00000398074.3
|
PDGFRL
|
platelet-derived growth factor receptor-like |
| chr3_+_50192499 | 0.94 |
ENST00000413852.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr5_-_146833222 | 0.92 |
ENST00000534907.1
|
DPYSL3
|
dihydropyrimidinase-like 3 |
| chr2_+_131113580 | 0.91 |
ENST00000175756.5
|
PTPN18
|
protein tyrosine phosphatase, non-receptor type 18 (brain-derived) |
| chr7_-_38398721 | 0.90 |
ENST00000390346.2
|
TRGV3
|
T cell receptor gamma variable 3 |
| chr1_+_93297582 | 0.90 |
ENST00000370321.3
|
RPL5
|
ribosomal protein L5 |
| chr9_+_129622904 | 0.90 |
ENST00000319119.4
|
ZBTB34
|
zinc finger and BTB domain containing 34 |
| chr6_+_35310312 | 0.89 |
ENST00000448077.2
ENST00000360694.3 ENST00000418635.2 ENST00000444397.1 |
PPARD
|
peroxisome proliferator-activated receptor delta |
| chr6_+_33359582 | 0.88 |
ENST00000450504.1
|
KIFC1
|
kinesin family member C1 |
| chr14_+_22293618 | 0.88 |
ENST00000390432.2
|
TRAV10
|
T cell receptor alpha variable 10 |
| chr18_-_26941900 | 0.87 |
ENST00000577674.1
|
CTD-2515C13.2
|
CTD-2515C13.2 |
| chr16_+_48657361 | 0.87 |
ENST00000565072.1
|
RP11-42I10.1
|
RP11-42I10.1 |
| chr6_-_32920794 | 0.86 |
ENST00000395305.3
ENST00000395303.3 ENST00000374843.4 ENST00000429234.1 |
HLA-DMA
XXbac-BPG181M17.5
|
major histocompatibility complex, class II, DM alpha Uncharacterized protein |
| chr15_+_75074385 | 0.86 |
ENST00000220003.9
|
CSK
|
c-src tyrosine kinase |
| chr12_-_51663959 | 0.86 |
ENST00000604188.1
ENST00000398453.3 |
SMAGP
|
small cell adhesion glycoprotein |
| chr4_+_56815102 | 0.86 |
ENST00000257287.4
|
CEP135
|
centrosomal protein 135kDa |
| chr11_+_65837907 | 0.86 |
ENST00000320580.4
|
PACS1
|
phosphofurin acidic cluster sorting protein 1 |
| chr7_-_100425112 | 0.85 |
ENST00000358173.3
|
EPHB4
|
EPH receptor B4 |
| chr1_+_212208919 | 0.85 |
ENST00000366991.4
ENST00000542077.1 |
DTL
|
denticleless E3 ubiquitin protein ligase homolog (Drosophila) |
| chr15_+_63340734 | 0.85 |
ENST00000560959.1
|
TPM1
|
tropomyosin 1 (alpha) |
| chr11_-_64510409 | 0.85 |
ENST00000394429.1
ENST00000394428.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
| chr20_+_48807351 | 0.84 |
ENST00000303004.3
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta |
| chr17_+_16318850 | 0.84 |
ENST00000338560.7
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2 |
| chr6_+_35310391 | 0.84 |
ENST00000337400.2
ENST00000311565.4 ENST00000540939.1 |
PPARD
|
peroxisome proliferator-activated receptor delta |
| chr17_+_16318909 | 0.84 |
ENST00000577397.1
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2 |
| chr5_+_148521046 | 0.83 |
ENST00000326685.7
ENST00000356541.3 ENST00000309868.7 |
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr19_+_56165480 | 0.83 |
ENST00000450554.2
|
U2AF2
|
U2 small nuclear RNA auxiliary factor 2 |
| chr10_-_101769617 | 0.83 |
ENST00000324109.4
ENST00000342239.3 |
DNMBP
|
dynamin binding protein |
| chr2_+_69240415 | 0.82 |
ENST00000409829.3
|
ANTXR1
|
anthrax toxin receptor 1 |
| chr1_-_17766198 | 0.81 |
ENST00000375436.4
|
RCC2
|
regulator of chromosome condensation 2 |
| chr19_-_6481776 | 0.81 |
ENST00000543576.1
ENST00000590173.1 ENST00000381480.2 |
DENND1C
|
DENN/MADD domain containing 1C |
| chr17_+_7621045 | 0.79 |
ENST00000570791.1
|
DNAH2
|
dynein, axonemal, heavy chain 2 |
| chr4_-_120548779 | 0.79 |
ENST00000264805.5
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific |
| chr2_-_238305397 | 0.79 |
ENST00000409809.1
|
COL6A3
|
collagen, type VI, alpha 3 |
| chr11_+_73675873 | 0.79 |
ENST00000537753.1
ENST00000542350.1 |
DNAJB13
|
DnaJ (Hsp40) homolog, subfamily B, member 13 |
| chr19_-_33793430 | 0.79 |
ENST00000498907.2
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha |
| chr11_-_117102768 | 0.79 |
ENST00000532301.1
|
PCSK7
|
proprotein convertase subtilisin/kexin type 7 |
| chr1_-_139379 | 0.78 |
ENST00000423372.3
|
AL627309.1
|
Uncharacterized protein |
| chr19_-_19051993 | 0.78 |
ENST00000594794.1
ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3
|
homer homolog 3 (Drosophila) |
| chr5_-_146833803 | 0.77 |
ENST00000512722.1
|
DPYSL3
|
dihydropyrimidinase-like 3 |
| chr19_-_4791219 | 0.77 |
ENST00000598782.1
|
AC005523.3
|
AC005523.3 |
| chr5_-_139726181 | 0.77 |
ENST00000507104.1
ENST00000230990.6 |
HBEGF
|
heparin-binding EGF-like growth factor |
| chr2_+_90060377 | 0.77 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
| chr7_+_150706010 | 0.76 |
ENST00000475017.1
|
NOS3
|
nitric oxide synthase 3 (endothelial cell) |
| chr16_+_29127282 | 0.76 |
ENST00000562902.1
|
RP11-426C22.5
|
RP11-426C22.5 |
| chr9_-_139940608 | 0.76 |
ENST00000371601.4
|
NPDC1
|
neural proliferation, differentiation and control, 1 |
| chr15_+_92396920 | 0.74 |
ENST00000318445.6
|
SLCO3A1
|
solute carrier organic anion transporter family, member 3A1 |
| chr2_-_72375167 | 0.74 |
ENST00000001146.2
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1 |
| chr8_+_22446763 | 0.73 |
ENST00000450780.2
ENST00000430850.2 ENST00000447849.1 |
AC037459.4
|
Uncharacterized protein |
| chr19_+_1941117 | 0.73 |
ENST00000255641.8
|
CSNK1G2
|
casein kinase 1, gamma 2 |
| chr9_-_140317605 | 0.73 |
ENST00000479452.1
ENST00000465160.2 |
EXD3
|
exonuclease 3'-5' domain containing 3 |
| chr14_+_22433675 | 0.73 |
ENST00000390442.3
|
TRAV12-3
|
T cell receptor alpha variable 12-3 |
| chr8_-_145550571 | 0.73 |
ENST00000332324.4
|
DGAT1
|
diacylglycerol O-acyltransferase 1 |
| chr11_+_44117219 | 0.73 |
ENST00000532479.1
ENST00000527014.1 |
EXT2
|
exostosin glycosyltransferase 2 |
| chr12_-_7261772 | 0.72 |
ENST00000545280.1
ENST00000543933.1 ENST00000545337.1 ENST00000544702.1 ENST00000266542.4 |
C1RL
|
complement component 1, r subcomponent-like |
| chr19_+_58341656 | 0.72 |
ENST00000442832.4
ENST00000594901.1 |
ZNF587B
|
zinc finger protein 587B |
| chrX_-_71497148 | 0.72 |
ENST00000316084.6
|
RPS4X
|
ribosomal protein S4, X-linked |
| chr10_-_6622258 | 0.72 |
ENST00000263125.5
|
PRKCQ
|
protein kinase C, theta |
| chr22_+_23077065 | 0.72 |
ENST00000390310.2
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
| chr12_-_51663728 | 0.72 |
ENST00000603864.1
ENST00000605426.1 |
SMAGP
|
small cell adhesion glycoprotein |
| chr11_-_66103932 | 0.71 |
ENST00000311320.4
|
RIN1
|
Ras and Rab interactor 1 |
| chr9_-_140317676 | 0.71 |
ENST00000342129.4
ENST00000340951.4 |
EXD3
|
exonuclease 3'-5' domain containing 3 |
Network of associatons between targets according to the STRING database.
First level regulatory network of RAD21_SMC3
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 3.9 | GO:0072573 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) |
| 1.0 | 2.9 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.7 | 2.9 | GO:1904588 | cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.7 | 2.0 | GO:0035981 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.6 | 2.3 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.5 | 2.2 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
| 0.5 | 2.1 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.4 | 1.3 | GO:0060661 | proximal/distal axis specification(GO:0009946) bronchiole development(GO:0060435) submandibular salivary gland formation(GO:0060661) secretion by lung epithelial cell involved in lung growth(GO:0061033) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.4 | 3.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.4 | 1.7 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.4 | 1.2 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.4 | 3.0 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.4 | 3.2 | GO:0003383 | apical constriction(GO:0003383) |
| 0.4 | 1.4 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.3 | 1.0 | GO:0052552 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.3 | 1.0 | GO:2000625 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 0.3 | 1.4 | GO:0035712 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.3 | 1.0 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.3 | 1.0 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.3 | 1.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.3 | 1.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.3 | 2.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.3 | 1.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.3 | 0.9 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 0.3 | 2.0 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.3 | 0.8 | GO:0045799 | negative regulation of nucleobase-containing compound transport(GO:0032240) positive regulation of chromatin assembly or disassembly(GO:0045799) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.3 | 0.8 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.3 | 2.5 | GO:1990834 | response to odorant(GO:1990834) |
| 0.2 | 1.8 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.2 | 4.3 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.2 | 1.1 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) operant conditioning(GO:0035106) |
| 0.2 | 0.7 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.2 | 0.9 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.2 | 1.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.2 | 1.8 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 | 1.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.2 | 0.6 | GO:2000724 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
| 0.2 | 1.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 | 6.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.2 | 0.5 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.2 | 1.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.2 | 0.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.2 | 0.8 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.2 | 0.8 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.2 | 0.8 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
| 0.2 | 2.4 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.1 | 0.6 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.1 | 0.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 | 1.9 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.1 | 21.2 | GO:0030449 | regulation of complement activation(GO:0030449) |
| 0.1 | 0.5 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.1 | 1.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.1 | 0.9 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 | 0.5 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.1 | 1.1 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 0.1 | 0.4 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.1 | 1.7 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 | 1.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.1 | 1.7 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.1 | 1.0 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 | 0.5 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
| 0.1 | 0.7 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.1 | 0.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 | 2.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.1 | 0.2 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
| 0.1 | 2.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 | 0.8 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.1 | 0.2 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.1 | 0.7 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.1 | 0.4 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 | 0.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 | 0.4 | GO:0060266 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.1 | 1.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 | 3.4 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 1.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.1 | 0.2 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.1 | 0.6 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.1 | 0.9 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.1 | 0.6 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 0.2 | GO:2000283 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.1 | 0.7 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.1 | 0.4 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 | 0.2 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.1 | 0.3 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 | 2.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 0.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.1 | 0.8 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 | 13.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.1 | 0.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 1.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 | 1.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.1 | 1.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 2.5 | GO:0060065 | uterus development(GO:0060065) |
| 0.1 | 0.5 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.1 | 0.9 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.1 | 0.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.1 | 0.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 | 0.4 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 | 0.7 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.1 | 3.9 | GO:0097435 | fibril organization(GO:0097435) |
| 0.1 | 0.1 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.1 | 0.2 | GO:0071106 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.1 | 1.7 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.1 | 0.5 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 | 1.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 | 0.3 | GO:0060426 | lung vasculature development(GO:0060426) |
| 0.1 | 0.1 | GO:0035989 | tendon development(GO:0035989) tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.1 | 1.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.1 | 0.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 | 0.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 | 1.2 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.1 | 0.3 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.1 | 1.6 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.1 | 0.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 | 1.0 | GO:0051608 | histamine transport(GO:0051608) |
| 0.0 | 0.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.0 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.0 | 0.5 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.0 | 0.5 | GO:2000344 | cellular response to potassium ion(GO:0035865) positive regulation of acrosome reaction(GO:2000344) |
| 0.0 | 0.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 | 0.3 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 0.0 | 0.1 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.0 | 0.4 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.0 | 0.1 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.0 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 | 1.3 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.0 | 1.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 | 1.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.0 | 1.0 | GO:0007601 | visual perception(GO:0007601) sensory perception of light stimulus(GO:0050953) |
| 0.0 | 0.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 0.2 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) beta-alanine metabolic process(GO:0019482) thymine metabolic process(GO:0019859) uracil metabolic process(GO:0019860) deoxyribonucleoside catabolic process(GO:0046121) |
| 0.0 | 0.9 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.0 | 0.7 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.0 | 0.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.0 | 0.3 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.0 | 0.2 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.0 | 0.2 | GO:0006272 | leading strand elongation(GO:0006272) |
| 0.0 | 1.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.0 | 0.3 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.0 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.0 | 2.3 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
| 0.0 | 2.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.0 | 0.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.0 | 0.2 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.0 | 5.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 | 0.1 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.0 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 | 5.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 | 0.1 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.0 | 0.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 | 2.8 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 | 0.1 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.0 | 1.1 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 | 0.7 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
| 0.0 | 1.7 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
| 0.0 | 0.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.0 | 0.1 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.0 | 2.5 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.1 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 0.0 | 2.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 | 3.6 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 | 0.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 | 1.8 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 | 0.1 | GO:1901490 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) regulation of lymphangiogenesis(GO:1901490) |
| 0.0 | 0.5 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.0 | 0.4 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.0 | 0.4 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 | 0.2 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.0 | 0.4 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 | 0.3 | GO:0060348 | bone development(GO:0060348) |
| 0.0 | 0.2 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.0 | 0.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.0 | 1.3 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.0 | 0.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
| 0.0 | 0.6 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 1.1 | GO:0038202 | TORC1 signaling(GO:0038202) |
| 0.0 | 0.5 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.0 | 1.5 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
| 0.0 | 0.4 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.0 | 0.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.0 | 0.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 | 0.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.0 | 0.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 | 0.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.0 | 0.3 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.0 | 0.1 | GO:0071048 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 | 0.1 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.0 | 0.0 | GO:0072679 | thymocyte migration(GO:0072679) |
| 0.0 | 0.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 | 0.3 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.0 | 0.8 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.0 | 0.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.0 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 | 0.1 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.0 | 0.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.0 | 0.3 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.0 | 0.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.0 | 1.1 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 | 0.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 0.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.0 | 0.1 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 0.0 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.0 | 1.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
| 0.0 | 1.0 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 | 0.4 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.0 | 0.8 | GO:0007405 | neuroblast proliferation(GO:0007405) |
| 0.0 | 0.9 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.0 | 0.5 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.0 | 0.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.0 | 0.1 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.0 | 0.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.0 | 0.0 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.0 | 0.4 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.0 | 0.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.0 | 0.1 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.0 | 1.9 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
| 0.0 | 0.4 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 | 0.7 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 | 0.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 | 0.1 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.0 | 0.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 | 1.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 | 0.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.0 | 0.6 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.0 | 0.1 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 2.3 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.6 | 1.1 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.4 | 1.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.3 | 1.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.2 | 1.5 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.2 | 2.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.2 | 1.0 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.2 | 3.8 | GO:0005861 | troponin complex(GO:0005861) |
| 0.1 | 3.0 | GO:0032059 | bleb(GO:0032059) |
| 0.1 | 1.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.1 | 0.4 | GO:0035101 | FACT complex(GO:0035101) |
| 0.1 | 1.6 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 1.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 0.8 | GO:0089701 | U2AF(GO:0089701) |
| 0.1 | 1.3 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.1 | 1.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.1 | 0.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.1 | 0.3 | GO:0000806 | Y chromosome(GO:0000806) cyclin A2-CDK2 complex(GO:0097124) cyclin E1-CDK2 complex(GO:0097134) |
| 0.1 | 1.6 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.1 | 1.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 1.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 0.1 | 0.6 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.1 | 1.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.1 | 0.6 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.1 | 1.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.1 | 0.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.1 | 1.0 | GO:0072487 | MSL complex(GO:0072487) |
| 0.1 | 0.2 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.1 | 0.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.1 | 0.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.1 | 0.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 2.9 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.1 | 2.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 2.0 | GO:0032982 | myosin filament(GO:0032982) |
| 0.1 | 7.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 0.4 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.1 | 0.8 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.1 | 0.4 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.0 | 0.1 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.0 | 0.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.0 | 0.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.0 | 2.8 | GO:0000791 | euchromatin(GO:0000791) |
| 0.0 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.0 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.0 | 0.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.0 | 0.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.0 | 5.3 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.0 | 0.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.0 | 2.8 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 0.8 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.0 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.0 | 0.6 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.0 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.0 | 2.5 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 2.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 0.0 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.0 | 0.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.0 | 0.5 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.0 | 0.2 | GO:0042825 | TAP complex(GO:0042825) |
| 0.0 | 0.5 | GO:0090543 | Flemming body(GO:0090543) |
| 0.0 | 0.7 | GO:0042641 | actomyosin(GO:0042641) |
| 0.0 | 2.6 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.0 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
| 0.0 | 1.8 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.0 | 0.2 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
| 0.0 | 0.3 | GO:0030681 | multimeric ribonuclease P complex(GO:0030681) |
| 0.0 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
| 0.0 | 3.1 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
| 0.0 | 1.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.0 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.0 | 1.6 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 2.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.0 | 5.6 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 1.2 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 1.3 | GO:0005874 | microtubule(GO:0005874) |
| 0.0 | 0.2 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 1.5 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.0 | 0.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.0 | 0.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.0 | 0.6 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.0 | 1.2 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 0.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.0 | 0.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.0 | 0.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.0 | 2.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.1 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
| 0.0 | 1.3 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.0 | 11.3 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 1.9 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 2.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.0 | 1.5 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 1.9 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.0 | 1.4 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 1.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.0 | 0.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.0 | 0.2 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
| 0.0 | 5.8 | GO:0000785 | chromatin(GO:0000785) |
| 0.0 | 0.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.0 | 0.8 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.0 | 17.6 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 6.1 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.0 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 2.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.4 | 1.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.4 | 1.3 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.4 | 1.7 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.4 | 2.9 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.4 | 1.1 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.3 | 3.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.3 | 1.7 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.3 | 2.2 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.3 | 3.8 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.3 | 1.8 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.3 | 1.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.2 | 1.2 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.2 | 0.9 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
| 0.2 | 1.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.2 | 3.9 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.2 | 2.1 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.2 | 0.6 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
| 0.2 | 2.8 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.2 | 0.5 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.2 | 1.6 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.2 | 0.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.2 | 1.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.1 | 0.4 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.1 | 1.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.1 | 2.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 0.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.1 | 0.8 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.1 | 2.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 2.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.1 | 0.4 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.1 | 1.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.1 | 1.0 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 29.9 | GO:0003823 | antigen binding(GO:0003823) |
| 0.1 | 1.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.1 | 1.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.1 | 0.2 | GO:0046977 | peptide antigen-transporting ATPase activity(GO:0015433) TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
| 0.1 | 0.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.1 | 1.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.1 | 0.8 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 0.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 0.3 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
| 0.1 | 2.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 0.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.1 | 1.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.1 | 0.2 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.1 | 1.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.1 | 1.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.1 | 0.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.1 | 0.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 1.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.1 | 1.7 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
| 0.1 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.2 | GO:0071077 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 0.1 | 6.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.1 | 2.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.1 | 1.7 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 1.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.2 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.1 | 1.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 1.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.1 | 0.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.1 | 4.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.0 | 0.7 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.0 | 1.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.0 | 0.7 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.0 | 0.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.0 | 0.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.0 | 1.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.0 | 0.1 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.0 | 1.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.0 | 5.2 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.0 | 1.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.0 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.0 | 6.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 5.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.0 | 1.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.0 | 1.1 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.0 | 0.5 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.0 | 1.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 0.8 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.0 | 0.2 | GO:0016530 | metallochaperone activity(GO:0016530) |
| 0.0 | 1.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.0 | 0.7 | GO:0046983 | protein dimerization activity(GO:0046983) |
| 0.0 | 0.7 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.0 | 9.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 0.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.0 | 0.6 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.0 | 0.3 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.0 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.0 | 7.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.0 | 2.2 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.0 | 0.1 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.0 | 1.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.0 | 0.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.0 | 0.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.0 | 0.5 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.0 | 1.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.0 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.0 | 0.8 | GO:0043495 | protein anchor(GO:0043495) |
| 0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.0 | 0.8 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.0 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.0 | 0.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.0 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.0 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.0 | 0.2 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.0 | 1.6 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
| 0.0 | 4.2 | GO:0019838 | growth factor binding(GO:0019838) |
| 0.0 | 0.5 | GO:0070001 | aspartic-type peptidase activity(GO:0070001) |
| 0.0 | 0.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.0 | 0.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.0 | 1.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 1.4 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.0 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.0 | 0.3 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.0 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.0 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
| 0.0 | 0.7 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
| 0.0 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.0 | 0.5 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.0 | 0.3 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.0 | 0.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.0 | 0.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.0 | 0.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.0 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.0 | 0.4 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.0 | 0.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.0 | 0.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 1.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.0 | 1.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.8 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 0.0 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.0 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.0 | 1.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.0 | 2.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 0.6 | GO:0043531 | ADP binding(GO:0043531) |
| 0.0 | 0.7 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 3.7 | GO:0008022 | protein C-terminus binding(GO:0008022) |
| 0.0 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.0 | 0.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
| 0.0 | 0.1 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.0 | 0.1 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.0 | 0.1 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.1 | 6.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 2.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 6.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.1 | 4.1 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.1 | 4.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 2.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.1 | 2.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.1 | 2.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 1.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 2.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 1.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.0 | 3.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 1.8 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.0 | 2.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.0 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.0 | 1.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.0 | 0.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.0 | 1.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 1.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 2.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 1.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 2.4 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 1.9 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 0.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.0 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 2.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.0 | 2.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 0.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 1.7 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.0 | 1.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 2.6 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 0.9 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 0.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 2.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 1.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 6.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 1.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 1.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 3.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.0 | 0.6 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 3.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 0.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 2.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.1 | 9.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 3.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 1.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 2.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.1 | 2.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 2.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 2.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.1 | 1.7 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.1 | 4.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.1 | 1.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 1.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.1 | 1.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.1 | 2.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 1.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.1 | 9.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.1 | 1.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.1 | 1.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 4.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 2.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.0 | 0.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.0 | 1.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.0 | 1.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.0 | 2.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.0 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.0 | 0.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.0 | 1.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.0 | 0.8 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
| 0.0 | 0.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.0 | 3.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 0.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.0 | 1.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 0.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.0 | 0.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.0 | 0.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.0 | 0.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 0.8 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.0 | 1.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 0.9 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.0 | 0.8 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
| 0.0 | 0.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 1.8 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.0 | 4.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 2.8 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.0 | 0.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.0 | 2.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 0.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 0.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 1.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.0 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.0 | 1.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.0 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.0 | 1.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 0.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |